Get RYTARY—a Parkinson’s
medication
that can help
the real you shine through.
People who switched from immediate-release carbidopa/levodopa (IR CD/LD) to RYTARY experienced:
2X
reduction in “off” time
during waking hours
- After switching to RYTARY, people had significantly less “off” time than they did when taking IR
CD/LD
— Percentage of “off” time at study start and study end: 36.9% and 23.8% with RYTARY vs 36.0% and 29.8% with IR CD/LD*
2X
increase in “on” time without
troublesome dyskinesia
throughout the day†
- After switching to RYTARY, people had significantly more “on” time without troublesome
dyskinesia
than they did when taking IR CD/LD
— 1.8 hours with RYTARY vs 0.8 hours with IR CD/LD‡
Better movement control†
- After switching to RYTARY, people also experienced a significant improvement in motor functions, which can help when performing daily activities
+1.2
hours greater increase
in “on” time per dose§
- A different analysis of the same study found that optimized RYTARY provided more hours per dose
of
“on” time compared to optimized IR CD/LD
— Hours of “on” time per dose at baseline and study end: 2.17 and 3.55 with RYTARY vs 2.24 and 2.38 with IR CD/LD
In a clinical study, the most common side effects occurring in at least 5% of people treated with RYTARY and at a higher rate than IR CD/LD were nausea and headache.
*Study end=Week 22 or early termination; P<0.0001 vs IR CD/LD.†These were secondary measures of the study.
‡P=0.0002 vs IR CD/LD.
§This was a post hoc analysis of the study; P<0.0001 vs IR CD/LD.
You are not your disease.
You are a unique individual who happens to have Parkinson’s.
So let your story be heard.
Be your own health advocate.Denise, on RYTARY since 2016